Wildlife Pharmaceuticals and its subsidiary, ZooPharm, the legacy of retired Bill Lance, DVM, MS, PhD, are now part of the largest veterinary-compounding pharmacy in the U.S., Wedgewood Pharmacy, a respected name known to 9 in 10 veterinarians in the U.S. The acquisition was completed this past summer.
ZooPharm is a veterinary compounding pharmacy that provides veterinary-anesthesia and pain-management medications to care for non-domestic species, resident wildlife, captive exotic breeds, and companion animals. Its medications include the BAM™ Kit, which includes a patented combination of Butorphanol tartrate, Azaperone tartrate, and Medetomidine hydrochloride that is used to immobilize a broad range of species, along with a reversal agent; a patented, slow-release Buprenorphine prescribed primarily to companion animals for post-operative recovery; and sustained-release analgesics and anesthetics used to manage pain. The company is licensed in 49 states.
People ask me about the relationship among the three companies. Wildlife Pharmaceuticals is the parent company of ZooPharm, develops unique compounded formulations to meet veterinarians’ needs, and manages ZooPharm’s business. ZooPharm is a state-regulated compounding pharmacy, licensed in 49 states that manages the pharmacy’s unique formulary. The new owner, Wedgewood Pharmacy is actively and aggressively working on ways to enhance our combined services and compounded formulations to make them available more widely.
Unlike Wedgewood Pharmacy, which offers more than 40,000 compounded formulations using more than 400 active pharmaceutical ingredients, the ZooPharm brand is the leader in developing, compounding, and delivering highly specialized and novel pharmaceutical formulations. These include its patented immobilization drug combinations and their reversal antagonists; sustained release analgesics; and uncommon, hard-to-find anesthetics and sedatives.
What’s changed? Today, any changes should be transparent to current customers. We are strongly committed to maintaining and extending the truly remarkable customer service experience and innovation that are the Wildlife Pharmaceuticals and ZooPharm’s hallmarks. We are working diligently towards applying for a license in North Carolina which, if granted, will allow us to resume shipping products to that state. We expect to file for this license in the next month or two. While we can’t give assurances about whether or not the license will be granted, we value our customers in North Carolina and hope to resume our relationships with them in the near future. For now, ZooPharm customers can continue to look to ZooPharm for its unique formulations and customer service. Meanwhile, we are focusing Wedgewood Pharmacy’s unique market position and resources to enhance formulations and services to all of our customers. By George Carballo, General Manager, Wildlife Pharmaceuticals
About the Author
George Carballo is general manager of Wildlife Pharmaceuticals. He leads the Wildlife Pharmaceuticals and ZooPharm business including developing the team, coordinating resources with Wedgewood Pharmacy, building and expanding customer relationships, and spurring research and new formulation development. Carballo joined Wedgewood Pharmacy in October 2018 as the regional sales manager for the Eastern Region. Prior to joining Wedgewood Pharmacy, he spent 16 years at Henry Schein Animal Health as a territory manager and then regional manager. His first experience in the animal-health arena was with Fort Dodge Animal Health where he was a territory manager. He began his career in account management and sales in the health insurance industry. He holds a Bachelor of Arts degree in biology from Rutgers University.